mhurhangee/ep-ind-claims huggingface dataset:
Device for measuring the knee laxity, with use of additional means of diagnosis such as computed axial tomography and magnetic resonance imaging, evaluating the instability of the knee due to rupture of any ligament, namely the anterior cruciate ligament, posterior cruciate ligament, postero-internal capsule, postero-external capsule, as well as around the axis of an orthonormal, anterior, posterior, antero-internal, antero-external, postero-internal and postero-external referential and comprising a part for receiving and holding the thigh with belts, a part (3, 8, 9) for receiving and holding the leg, a part (4, 5) for receiving and holding the foot with belts, wherin it includes: - two independent means (20 and 21) for pushing backward the anterior zone of the leg and for pushing forward the posterior zone of the leg, the two independent means are respectively located in the inner wall of a removable part for posterior support and fixation of the leg, and in the inner wall of a removable part for front support and fixation of the leg; - two further independent means (12 and 13) for pushing clockwise a part for support and fixation of the foot and for pushing anti-clockwise the part for support and fixation of the foot, the two further independent means are respectively located in the inner wall of the right and left sides of a supporting piece; wherein the part for support and fixation of the foot rotates clockwise or anticlockwise, depending on the force exerted on it, around a shaft that runs through said part for support and fixation of the foot and through the supporting piece which is articulated therein. - two independent means (20 and 21) for pushing backward the anterior zone of the leg and for pushing forward the posterior zone of the leg, the two independent means are respectively located in the inner wall of a removable part for posterior support and fixation of the leg, and in the inner wall of a removable part for front support and fixation of the leg; - two further independent means (12 and 13) for pushing clockwise a part for support and fixation of the foot and for pushing anti-clockwise the part for support and fixation of the foot, the two further independent means are respectively located in the inner wall of the right and left sides of a supporting piece;
An endoscopic system for producing images of tissue comprising a medical device arranged for delivering an illumination light to a body cavity and a color image sensor arranged for producing images of the tissue from a number of pixels that are sensitive to different wavelengths of light, and further comprising: an image processor arranged for receiving signals produced by the color image sensor in response to illumination light reflected from the tissue having red, green, and blue color components, wherein the image processor is arranged for calculating image signals that are stored in a memory reducing the contribution from signals produced by the image sensor in response to red illumination light, wherein the image sensor is an RGB sensor having pixels that are sensitive to red, green, and blue light, and wherein for generating a false color image of the tissue the image processor is arranged for providing the signals obtained from the pixels that are sensitive to blue and green light, respectively, to two of the color inputs of a color video monitor, and providing a combination of the signals produced from the pixels that are sensitive to blue and green light to a third color input of the color video monitor. an image processor arranged for receiving signals produced by the color image sensor in response to illumination light reflected from the tissue having red, green, and blue color components, wherein the image processor is arranged for calculating image signals that are stored in a memory reducing the contribution from signals produced by the image sensor in response to red illumination light, wherein the image sensor is an RGB sensor having pixels that are sensitive to red, green, and blue light, and wherein for generating a false color image of the tissue the image processor is arranged for providing the signals obtained from the pixels that are sensitive to blue and green light, respectively, to two of the color inputs of a color video monitor, and providing a combination of the signals produced from the pixels that are sensitive to blue and green light to a third color input of the color video monitor.
A method of producing a purine nucleoside represented by the formula (I') or a salt thereof, which comprising reacting a pyrimidine nucleoside represented by the formula or a salt thereof with a purine nucleobase represented by the formula B'H in toluene, in the presence of a Lewis acid and a silylating agent: wherein R 1 and R 1 ' are each independently a hydrogen atom, a hydroxy-protecting group, an alkyl group, an alkenyl group, a cycloalkyl group, an aryl group optionally having substituent (s), an aralkyl group optionally having substituent (s), an acyl group, an aliphatic or aromatic sulfonyl group or a silyl group, R 2 and R 2 ' are each independently a hydrogen atom, a hydroxy-protecting group, an alkyl group, an alkenyl group, a cycloalkyl group, an aryl group optionally having substituent(s), an aralkyl group optionally having substituent(s), an acyl group, an aliphatic or aromatic sulfonyl group or a silyl group, or R 1 and R 2 in combination or R 1 ' and R 2 ' in combination optionally form a group represented by the formula wherein R 4 in the number of p, R 5 in the number of p, R 6 and R 7 are each independently an alkyl group or an aryl group, and p is an integer of 1 to 3, R 3 is a hydrogen atom, an alkyl group, an alkenyl group, a cycloalkyl group, an aryl group optionally having substituent(s), an aralkyl group optionally having substituent(s), an acyl group, an aliphatic or aromatic sulfonyl group or a functional molecular unit substituent, selected from residues derived from labelling molecules, residues derived from molecules with DNA- or RNA-cleavage activity, residues derived from intracellular signal peptides and residues derived from membrane and permeable peptides, B is a residue derived from a pyrimidine nucleobase optionally having substituent(s), B' is a residue derived from a purine nucleobase optionally having substituent(s), m is an integer of 0 to 2, and n is an integer of to 3.
A linear motor comprising: a secondary side including magnets and ladder-shaped members of a magnetic material, the magnets and the ladder-shaped members of a magnetic material being arranged in alternate manner in a rectilinearly moving direction of the secondary side, each of the ladder-shaped members holding one of the magnets; and a primary side including magnetic pole pieces arranged in close proximity to the secondary side from above and below in a direction perpendicular to the rectilinearly moving direction with a common coil wound around each of the magnetic pole pieces, the primary side including a magnetic material core interconnecting the magnetic pole pieces; wherein each of the ladder-shaped members of a magnetic material is formed with a groove characterized in that the groove is disposed between the magnets adjacent each other. a secondary side including magnets and ladder-shaped members of a magnetic material, the magnets and the ladder-shaped members of a magnetic material being arranged in alternate manner in a rectilinearly moving direction of the secondary side, each of the ladder-shaped members holding one of the magnets; and a primary side including magnetic pole pieces arranged in close proximity to the secondary side from above and below in a direction perpendicular to the rectilinearly moving direction with a common coil wound around each of the magnetic pole pieces, the primary side including a magnetic material core interconnecting the magnetic pole pieces; wherein each of the ladder-shaped members of a magnetic material is formed with a groove characterized in that the groove is disposed between the magnets adjacent each other.
A valve assembly for regulating the supply of fluid from a fluid manifold to a working chamber of a fluid working machine, the valve comprising a primary valve (10, 12), an electromagnet and an armature, the primary valve comprising a face-seating primary valve member and a primary valve seat and having an open position in which the primary valve member is spaced apart from the primary valve seat and a sealing position in which the primary valve member is in sealing contact with the primary valve seat, wherein the armature is slidable along a path extending between a first position and a second position and moveable relative to the primary valve member and wherein, when the armature is in the first position, the primary valve member is biased towards the sealing position, and wherein, when the armature is in the second position, the primary valve member is biased towards the open position, characterised in that the primary valve member comprises a ferromagnetic member and the valve further comprises a magnetic circuit (2, 4, 28) adapted to direct magnetic flux through the ferromagnetic member when the primary valve is open to thereby hold the primary valve member in the open position.
A compound of the following formula I: wherein n is 1 to 20; R 1, R 2, and R 3 are each independently a C 2 -C 20 alkanediyl group, a C 3 -C 20 cycloalkanediyl group, a C 6 -C 20 arenediyl group, or a C 7 -C 20 aralkanediyl group; X and Y are each NH; at least one of A 1 and A 2 is -C -R 5; -CH 2 -CH R 6; -CR 7 =CH-C -O-(CH 2) p R 8; -C -Y'-(CH 2) p R 9; or CH 2 -CH 2 -C -O-R 10; wherein each R 5 is independently a C 2 -C 20 alkyl group, a C 3 -C 20 cycloalkyl group, a C 6 -C 20 aryl group, or a C 7 -C 20 aralkyl group, with the proviso that at least one R 5 is functionalized with a carboxylic acid group or a polymerizable olefin group or both; each R 6 is independently -CH 2 -acrylate, -CH 2 -methacrylate, or - (CH 2) p -COOH; each R 7 is independently H or CH 3; each R 8 is independently an acrylate group, a methacrylate group, or COOH; each R 9 is independently an acrylate group or a methacrylate group; each R 10 is independently H or -CH 2 CH=CH 2; Y' is O or NR 4; each p is independently from 2 to 6; and the compound has an M n in the range of 1000 to 6000 Daltons. wherein n is 1 to 20; R 1, R 2, and R 3 are each independently a C 2 -C 20 alkanediyl group, a C 3 -C 20 cycloalkanediyl group, a C 6 -C 20 arenediyl group, or a C 7 -C 20 aralkanediyl group; X and Y are each NH; at least one of A 1 and A 2 is -C -R 5; -CH 2 -CH R 6; -CR 7 =CH-C -O-(CH 2) p R 8; -C -Y'-(CH 2) p R 9; or CH 2 -CH 2 -C -O-R 10; wherein each R 5 is independently a C 2 -C 20 alkyl group, a C 3 -C 20 cycloalkyl group, a C 6 -C 20 aryl group, or a C 7 -C 20 aralkyl group, with the proviso that at least one R 5 is functionalized with a carboxylic acid group or a polymerizable olefin group or both; each R 6 is independently -CH 2 -acrylate, -CH 2 -methacrylate, or - (CH 2) p -COOH; each R 7 is independently H or CH 3; each R 8 is independently an acrylate group, a methacrylate group, or COOH; each R 9 is independently an acrylate group or a methacrylate group; each R 10 is independently H or -CH 2 CH=CH 2; Y' is O or NR 4; each p is independently from 2 to 6; and the compound has an M n in the range of 1000 to 6000 Daltons.
A method of treating an ammonia-containing purge gas stream from an engine on a marine or seagoing vessel comprising at least the steps of: (a) in a first stage, providing the ammonia-containing purge gas stream from the vessel engine; (b) passing the ammonia-containing purge gas stream through a first tank containing water to provide a reduced-ammonia vent gas stream; (c) in a second stage, providing a second tank containing a caustic solution; (d) passing the caustic solution from the second tank into the first tank to provide a resultant solution and a gaseous ammonia stream; and (e) passing the gaseous ammonia stream to a storage tank or a reliquefaction unit; (f) in a third stage, passing the resultant solution from the first tank into the second tank; (g) heating the resultant solution in the second tank to provide a water vapour stream and a recharged caustic solution; (h) condensing the water vapour stream to provide a liquid water stream; and (i) passing the liquid water stream into the first tank to provide the water of step (b). (a) in a first stage, providing the ammonia-containing purge gas stream from the vessel engine; (b) passing the ammonia-containing purge gas stream through a first tank containing water to provide a reduced-ammonia vent gas stream; (c) in a second stage, providing a second tank containing a caustic solution; (d) passing the caustic solution from the second tank into the first tank to provide a resultant solution and a gaseous ammonia stream; and (e) passing the gaseous ammonia stream to a storage tank or a reliquefaction unit; (f) in a third stage, passing the resultant solution from the first tank into the second tank; (g) heating the resultant solution in the second tank to provide a water vapour stream and a recharged caustic solution; (h) condensing the water vapour stream to provide a liquid water stream; and (i) passing the liquid water stream into the first tank to provide the water of step (b).
A (i) statin and (ii) vitamin D for use in a method of treating or reducing the likelihood of a migraine in a subject in need thereof, wherein the method comprises administration of said statin and said vitamin D in combination to said subject to treat or reduce the likelihood of a migraine in said subject.
Method for checking delivery of content to a user terminal performed by a plurality of nodes (N1-N3) belonging to at least one content delivery network, said nodes being able to deliver one or more portions of the content, said method being implemented by a first node, called instigator node, selected from the plurality of nodes and comprising the following steps: - calculating the results of comparisons, for a plurality of portions of the delivered content, of values of at least one actual telemetry datum with corresponding values of at least one expected telemetry datum, and characterized by the following additional steps: - receiving at least one result of the same comparisons made by at least one second node, called follower node (N2-N3), selected from the plurality of nodes, - acknowledging the delivery of portions of the content when at least a majority of the comparison results obtained indicate conformity of the values of at least one actual telemetry datum with the corresponding values of at least one expected telemetry datum. - calculating the results of comparisons, for a plurality of portions of the delivered content, of values of at least one actual telemetry datum with corresponding values of at least one expected telemetry datum, - receiving at least one result of the same comparisons made by at least one second node, called follower node (N2-N3), selected from the plurality of nodes, - acknowledging the delivery of portions of the content when at least a majority of the comparison results obtained indicate conformity of the values of at least one actual telemetry datum with the corresponding values of at least one expected telemetry datum.
Method for applying a fluorinated and/or ceramic, coloured coating on an internal wall of a low-diameter tube, such as a syringe needle, comprising the steps of: - suction and/or flow, in the tube, of a liquid containing the coating; - draining the liquid contained in the tube, at the end of which a coating deposit is obtained on the internal wall of the tube; - dissolving the coating by forced air circulation; - curing the coating; characterised in that it comprises a step of preparing the internal surface carried out by mechanical attack, the step of preparing the internal surface being carried out using a wire introduced in the internal tube and driven by a movement back and forth against the internal wall of the tube. - suction and/or flow, in the tube, of a liquid containing the coating; - draining the liquid contained in the tube, at the end of which a coating deposit is obtained on the internal wall of the tube; - dissolving the coating by forced air circulation; - curing the coating;
A vehicle comprising: a passenger compartment; a nose region forwards of the passenger compartment, the nose region having a top surface and a front; a duct running from an inlet to an outlet to permit air flowing into the inlet to be channelled to the outlet, the inlet being positioned at the front of the nose region below the top surface and the outlet being positioned on the top surface of the nose region behind the inlet, the outlet being oriented so that air flowing through the outlet is directed in an upwards direction and directed towards the front of the nose region, the upwards airflow causing disruption to a rearward airflow moving towards the passenger compartment; characterised by an airflow deflector positioned forward of the outlet, the airflow deflector projecting from the top surface of the nose region to direct a rearwardly moving airflow over the top surface of the nose region in an upwards direction to cause disruption to the rearward airflow moving towards the passenger compartment. a passenger compartment; a nose region forwards of the passenger compartment, the nose region having a top surface and a front; a duct running from an inlet to an outlet to permit air flowing into the inlet to be channelled to the outlet, the inlet being positioned at the front of the nose region below the top surface and the outlet being positioned on the top surface of the nose region behind the inlet, the outlet being oriented so that air flowing through the outlet is directed in an upwards direction and directed towards the front of the nose region, the upwards airflow causing disruption to a rearward airflow moving towards the passenger compartment; characterised by an airflow deflector positioned forward of the outlet, the airflow deflector projecting from the top surface of the nose region to direct a rearwardly moving airflow over the top surface of the nose region in an upwards direction to cause disruption to the rearward airflow moving towards the passenger compartment.
A process of making a linear dicarboxylic acid of C n chain length, comprising: (a) providing a feed which is a renewable resource; (b) contacting the feed with a catalyst in the presence of hydrogen to produce a hydrocarbon product having at least a 5:1 ratio of even-numbered alkanes to odd-numbered alkanes and comprising a linear alkane of C n chain length; (c) separating at least a portion of the linear alkane of C n chain length from the hydrocarbon product; and (d) fermenting at least a portion of the linear alkane of C n chain length to a linear dicarboxylic acid of C n chain length; wherein n = 10, 12, 14, 16 or 18; and wherein the catalyst comprises an oxide, molybdenum, nickel and cobalt; and the catalyst is in sulfided form. (a) providing a feed which is a renewable resource; (b) contacting the feed with a catalyst in the presence of hydrogen to produce a hydrocarbon product having at least a 5:1 ratio of even-numbered alkanes to odd-numbered alkanes and comprising a linear alkane of C n chain length; (c) separating at least a portion of the linear alkane of C n chain length from the hydrocarbon product; and (d) fermenting at least a portion of the linear alkane of C n chain length to a linear dicarboxylic acid of C n chain length;
A synergistic fungicidal mixture comprising: a fungicidally effective amount of a compound of Formula I: and at least one additional fungicide, wherein the at least one additional fungicide is (i) a fungicidal multi-site inhibitor, wherein the fungicidal multi-site inhibitor is selected from the group consisting of chlorothalonil, and mancozeb, or (ii) a strobilurin fungicide, wherein the strobilurin fungicide is selected from the group consisting of pyraclostrobin, fluoxastrobin, azoxystrobin, trifloxystrobin, picoxystrobin, and kresoxim-methyl. a fungicidally effective amount of a compound of Formula I: and at least one additional fungicide, wherein the at least one additional fungicide is (i) a fungicidal multi-site inhibitor, wherein the fungicidal multi-site inhibitor is selected from the group consisting of chlorothalonil, and mancozeb, or (ii) a strobilurin fungicide, wherein the strobilurin fungicide is selected from the group consisting of pyraclostrobin, fluoxastrobin, azoxystrobin, trifloxystrobin, picoxystrobin, and kresoxim-methyl.
Process for fabricating a recurrent-neural-network computer, comprising the successive steps of: a) providing a substrate comprising a first electrode; b) forming a first block-copolymer layer on one portion of the first electrode so that the first electrode contains free zones with a random spatial distribution; c) etching the free zones of the first electrode so as to structure the first electrode; d) removing the first block-copolymer layer; e) forming a resistive random-access memory layer on the first electrode structured in step c); f) forming a second electrode on the memory layer; g) forming a second block-copolymer layer on one portion of the second electrode so that the second electrode contains free zones with a random spatial distribution; h) etching the free zones of the second electrode so as to structure the second electrode; i) removing the second block-copolymer layer. a) providing a substrate comprising a first electrode; b) forming a first block-copolymer layer on one portion of the first electrode so that the first electrode contains free zones with a random spatial distribution; c) etching the free zones of the first electrode so as to structure the first electrode; d) removing the first block-copolymer layer; e) forming a resistive random-access memory layer on the first electrode structured in step c); f) forming a second electrode on the memory layer; g) forming a second block-copolymer layer on one portion of the second electrode so that the second electrode contains free zones with a random spatial distribution; h) etching the free zones of the second electrode so as to structure the second electrode; i) removing the second block-copolymer layer.
Use of a contamination barrier for preventing contaminations of aqueous solutions in open and/or automated systems that arise from carry-over and/or aerosol formation during pipetting, wherein said contamination barrier consists of silicone oil, or comprises a mixture of at least one silicone oil with at least one hydrocarbon not miscible with water or with a hydrocarbon mixture.